Clinical Trial 40253

Long Beach, CA 90806


Study Summary:

A Phase 2a, Multicenter, Randomized, Double-Blind,
Placebo-Controlled, 3-Arm Study to Assess the Safety, Tolerability,
PK Profile, and Symptom Response of a 7-Day Dosing with
REL-1017 25 mg QD and 50 mg QD as Adjunctive Therapy in the
Treatment of Patients Diagnosed with Major Depressive Disorder


Qualified Participants Must:

• Males and Females between 18 and 65 years of age
• Diagnosed with recurrent MDD


Qualified Participants May Receive:

Compensation for time and travel 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.